Results 71 to 80 of about 12,719 (213)
Introduction Many patients with chronic obstructive pulmonary disease (COPD) prescribed long-acting muscarinic antagonist (LAMA) monotherapy remain symptomatic.
Beth Hahn+5 more
doaj +1 more source
Shohei Kawachi,1 Keisaku Fujimoto21Department of Biomedical Laboratory Science, Graduate School of Medicine, Shinshu University, Nagano 390-8621, Japan; 2Department of Clinical Laboratory Sciences, Shinshu University School of Health Sciences, Matsumoto ...
Kawachi S, Fujimoto K
doaj
Isolated porcine bronchi provide a reliable model for development of bronchodilator anti‐muscarinic agents for human use [PDF]
Gianluigi D’Agostino+5 more
openalex +1 more source
Yasushi Fukushima,1 Yuji Nakatani,2 Yumiko Ide,3 Hisakuni Sekino,4 Earl St Rose,5 Shahid Siddiqui,6 Andrea Maes,5 Colin Reisner5,6 1Department of Internal Medicine, Fukuwa Clinic, Tokyo, Japan; 2Department of Internal Medicine, Nakatani Hospital, Hyogo,
Fukushima Y+7 more
doaj
Tracheal relaxing effects and β2 adrenoceptor selectivity of S1319, a novel sponge‐derived bronchodilator agent, in isolated guinea‐pig tissues [PDF]
Hidefumi Suzuki+7 more
openalex +1 more source
Acute bronchodilator responses to β2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation [PDF]
Satoshi Konno+6 more
openalex +1 more source
Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
Peter M Calverley,1 Göran Eriksson,2 Christine R Jenkins,3 Antonio R Anzueto,4 Barry J Make,5 Anders Persson,6 Malin Fagerås,6 Dirkje S Postma7 1Pulmonary and Rehabilitation Research Group, University Hospital Aintree, Liverpool, UK ...
Calverley PM+7 more
doaj
Cardiovascular morbidity and the use of inhaled bronchodilators
Christine Macie, Kate Wooldrage, Jure Manfreda, Nicholas AnthonisenDepartment of Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaAbstract: We used the Manitoba Health database to examine the relationship between use of inhaled respiratory ...
Christine Macie+3 more
doaj
Resumen: Introducción: En el tratamiento de los pacientes con bronquiolitis aguda existe una gran variabilidad de la práctica clínica y con frecuencia se utilizan de forma indiscriminada tratamientos cuya eficacia no está demostrada a pesar de las ...
David Andina Martínez+6 more
doaj
1702 At what age is ipratroprium bromide an effective bronchodilator agent in childhood asthma? [PDF]
A. David Milner+3 more
openalex +1 more source